Arrhythmia Research Technology, Inc. And Osmetech Plc Announce A 3-Year Supply Agreement

FITCHBURG, Mass.--(BUSINESS WIRE)--Arrhythmia Research Technology, Inc. (AMEX: HRT) announced that its wholly owned subsidiary Micron Products Inc. (“Micron”), has entered into a three-year supply agreement with the Molecular Diagnostics division of Osmetech plc (LSE: OMH). Micron, through its New England Molders division (“NEM”), will provide manufacturing services for consumables components used in Osmetech’s OPTI TUBE™ and OPTI GENE™ product lines.